French pharma group Ipsen sees more asset purchases, U.S. growth

PARIS (Reuters) – French pharma company Ipsen expects to bring more drugs to combat cancer, rare diseases and mobility impairment into its pipeline this year and has around one billion euros ($1.25 billion) for asset purchases, its chief executive said.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *